Get COVID-19 Vaccine Text Updates Enroll in the BioNTech & Pfizer COVID Connect text messaging program for U.S. Healthcare Professionals. Sign Up Call a Pfizer Connect Representative Live representatives available 9 AM–5 PM ET to help HCPs answer product questions, discuss Pfizer Prime orderin...
More On COVID-19Details A Multi-Pronged Approach to COVID-19 Explore how vaccinations and treatment with oral medication for those eligible are working to combat COVID-19. Learn More Now Making & Distributing Our Vaccine Pfizer consistently and diligently monitors the supply of our medicines. ...
"The U.S. FDA set a threshold of 50% effectiveness for a Covid-19 vaccine to merit approval. A 90% effective vaccine would be extraordinary," Dr. Peter Drobac, a global health physician and director of the Skoll Centre for Social Entrepreneurship at the University of Oxford,...
Pfizer-BioNTech COVID-19 Vaccine supplied in a multiple dose vial with a purple cap is authorized for use to provide: • a 2-dose primary series to individuals 12 years of age and older; and • a third primary series dose to individuals 12 years of age and older with certain kind...
The Studies We are proud to be part of developing the world's first COVID-19 vaccine, which has protected millions globally from this devastating disease. But our work is not done. Fighting COVID-19 requires adjustments to the vaccine to address new variants and provide ongoing protection. We...
In its analysis of Pfizer's data, the FDA said that rates of hospitalization and death due to COVID-19 among children under 5 were higher than among those aged 5 to 17, "underscoring the benefit of an effective COVID-19 vaccine in this age group." ...
Pfizersaid it had fully enrolled itsCovid-19vaccine trial in kids ages 12 to 15, a key step before the vaccine could be used in that age group. The study, an extension of the one used to support the company's Emergency Use Authorization of the vaccine in people 16 and...
A real-world test of Pfizer's COVID-19 vaccine in more than half a million people confirms that it's very effective at preventing serious illness or death, even after one dose. Wednesday's published results, from a mass vaccination campaign in Israel, give strong reassurance that the benefit...
BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year.
Scientists welcome the first compelling evidence that a vaccine can prevent COVID-19. But questions remain about how much protection it offers, to whom and for how long. By Ewen Callaway Twitter Facebook Email It works! Scientists have greeted with cautious optimism a press release declaring ...